Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Early Transition Strategies to Improve Outcomes in Patients with Cardiogenic Shock Supported by Veno-Arterial Extracorporeal Membrane Oxygenation

FY 2025-26

Summary
Cardiogenic shock (CS) is a life-threatening state of heart failure, where the heart is no longer capable of pumping enough blood throughout the body. This reduces the oxygen reaching the body’s tissues, leading to organ failure and, ultimately, death. The most critically ill patients often require life-saving support to take over the function of the failing heart and lungs, known as veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Although VA-ECMO provides vital short-term support, it can put undue pressure on the heart, leading to serious complications. Relieving the pressure in the heart is essential, and this can be done through various strategies, such as venting. However, we still do not know which venting strategy is best and when we should act on this. Additionally, it remains unclear for how long a patient should remain on VA-ECMO before undergoing alternative treatment. We hypothesize that earlier decision-making concerning the ideal venting strategy and optimal VA-ECMO duration will be associated with improved survival. We will collect individual patient information from 305 CS patients admitted to the University Health Network (UHN) from 2014-2025 who were supported with VA-ECMO and compare venting strategies and survival rates. In addition, we will perform a pilot randomized study of 20 patients to test whether early transition from VA-ECMO after 48 hours to an alternative type of circulatory support improves survival. With CS on the rise, understanding how to use VA-ECMO effectively is essential. Clarifying the benefits of early clinical decisions and how they affect survival could strengthen evidence-based care worldwide by guiding venting choices and the safe duration of support.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572635
Name
Halpern Jillian A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Early Transition Strategies to Improve Outcomes in Patients with Cardiogenic Shock Supported by Veno-Arterial Extracorporeal Membrane Oxygenation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cardiogenic Shock; Clinical Outcomes; Extracorporeal Membrane Oxygenation; Heart Failure; Impella; Intra-Aortic Balloon Pump; Mechanical Circulatory Support; Septostomy; Va-Ecmo; Venting Strategies
Abstract
Cardiogenic shock (CS) is a life-threatening state of heart failure, where the heart is no longer capable of pumping enough blood throughout the body. This reduces the oxygen reaching the body’s tissues, leading to organ failure and, ultimately, death. The most critically ill patients often require life-saving support to take over the function of the failing heart and lungs, known as veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Although VA-ECMO provides vital short-term support, it can put undue pressure on the heart, leading to serious complications. Relieving the pressure in the heart is essential, and this can be done through various strategies, such as venting. However, we still do not know which venting strategy is best and when we should act on this. Additionally, it remains unclear for how long a patient should remain on VA-ECMO before undergoing alternative treatment. We hypothesize that earlier decision-making concerning the ideal venting strategy and optimal VA-ECMO duration will be associated with improved survival. We will collect individual patient information from 305 CS patients admitted to the University Health Network (UHN) from 2014-2025 who were supported with VA-ECMO and compare venting strategies and survival rates. In addition, we will perform a pilot randomized study of 20 patients to test whether early transition from VA-ECMO after 48 hours to an alternative type of circulatory support improves survival. With CS on the rise, understanding how to use VA-ECMO effectively is essential. Clarifying the benefits of early clinical decisions and how they affect survival could strengthen evidence-based care worldwide by guiding venting choices and the safe duration of support.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Halpern, Jillian A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~